30/09/2026 09:16
|
Biotechnology
The first clinical programme from Currus’ BEAT platform, designed to overcome the barriers that have limited CAR T-cell therapy in solid tumours
CUR-001 combines CURB-001, Currus’ BEAT bispecific...